Source: Annual Congress 2005 - COPD - treatment I
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. R. Silva, P. Kawage, W. G. Filho, U. Nihlen, E. Ståhl (Sao Paulo, Brazil; Lund, Sweden). Budesonide/formoterol improves the wellbeing of patients with COPD: results from a real-life setting. Eur Respir J 2005; 26: Suppl. 49, 1931

Member's Comments

No comment yet.

Related content which might interest you: Dual bronchodilation with once-daily QVA149 improves dyspnea and health status and reduces symptoms and rescue medication use in patients with COPD: The IGNITE trials Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013 Budesonide/formoterol in a single inhaler improves health status in patients with COPD without increasing healthcare costs Source: Eur Respir J 2003; 22: Suppl. 45, 50s Year: 2003 QVA149 once-daily is safe and well tolerated and improves lung function and health status in Japanese patients with COPD: The ARISE study Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013 Physician assessment of asthma control in patients receiving omalizumab in a real-world setting Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012 Clinical predictors of the effectiveness of tiotropium in adults with symptomatic asthma: the real-life data Source: International Congress 2018 – Tests and trends in asthma Year: 2018 Budesonide/formoterol maintenance and reliever therapy for asthma compared to conventional best practice: a randomised real-life study Source: Eur Respir J 2006; 28: Suppl. 50, 613s Year: 2006 Inhaler competence and patient satisfaction with a DPI; results of two real-life studies in asthma and COPD Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 Health status changes in COPD patients after real-life switch from tiotropium or salmeterol/fluticasone to indacaterol/glycopyrronium using the EQ-5D-3L instrument: results from the POWER study Source: International Congress 2018 – COPD management Year: 2018 Once-daily QVA149 demonstrates superior improvements in patient-reported dyspnea compared to tiotropium in patients with moderate-to-severe COPD: The BLAZE study Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 Indacaterol/glycopyrronium (IND/GLY) is superior to salmeterol/fluticasone (SFC) in improving the health status of patients with moderate-to-very severe COPD: Results from the FLAME study Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016 Budesonide/formoterol for the treatment of COPD exacerbations in the primary healthcare setting Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008 Improvement in health status in patients with moderate to severe COPD after treatment with budesonide/formoterol in a single inhaler Source: Eur Respir J 2002; 20: Suppl. 38, 250s Year: 2002 Once-daily QVA149 provides clinically meaningful improvements in lung function and clinical outcomes Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics Year: 2013 Does 7-day working improve outcomes for COPD? Source: International Congress 2019 – COPD: epidemiology and spirometry Year: 2019 QVA149 is more efficacious than tiotropium and salmeterol/fluticasone combination (SFC) in improving patient-reported outcomes and lung function in COPD patients with moderate-to-severe baseline dyspnoea: The IGNITE trials Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015 Improving psychological symptoms with rehabilitation in COPD patients Source: International Congress 2019 – PG8 The role of exercise in prevention of pulmonary and extra-pulmonary impairments Year: 2019 Differences in proxy-reported and patient-reported outcomes: Assessing problematic activities of daily life in patients with COPD Source: International Congress 2016 – Respiratory nursing research: opening new perspectives on patient experiences Year: 2016 Assessment and therapy for COPD patients in real-life primary care Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008 Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD Year: 2013 Nurse-assisted medical management of COPD patients at home is cost effective and improves patients‘ satisfaction considerably Source: Eur Respir J 2007; 30: Suppl. 51, 191s Year: 2007